IL6R and cancer: IL-6R signaling can promote stemness, growth and inflammatory responses in A549 cells and hence interventions like the IL-6R-blocking antibody tocilizumab have been used to investigate anti-cancer and anti-inflammatory effects on these cells (Kim et al, 2015).